473 related articles for article (PubMed ID: 28776149)
21. The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community Oncologists.
Gajra A; Jeune-Smith Y; Fortier S; Feinberg B; Phillips E; Balanean A; Klepin HD
JCO Oncol Pract; 2022 Jul; 18(7):e1081-e1090. PubMed ID: 35263162
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
Grunfeld EA; Ramirez AJ; Maher EJ; Peach D; Young T; Albery IP; Richards MA
Br J Cancer; 2001 May; 84(9):1172-8. PubMed ID: 11336466
[TBL] [Abstract][Full Text] [Related]
23. Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives.
O'Neill SC; Taylor KL; Clapp J; Jayasekera J; Isaacs C; Mary Atieh Graham D; Goldberg SL; Mandelblatt J
J Health Commun; 2018; 23(7):679-686. PubMed ID: 30130477
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
Rajagopal S; Goodman PJ; Tannock IF
J Clin Oncol; 1994 Jun; 12(6):1296-304. PubMed ID: 8201392
[TBL] [Abstract][Full Text] [Related]
26. What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey.
Behl D; Jatoi A
J Palliat Med; 2010 Jul; 13(7):831-5. PubMed ID: 20636153
[TBL] [Abstract][Full Text] [Related]
27. Ambulatory Advanced Cancer Patients' and Oncologists' Estimates of Life Expectancy Are Associated with Patient Psychological Characteristics But Not Chemotherapy Use.
Cripe LD; Rand KL; Perkins SM; Tong Y; Schmidt KK; Hedrick DG; Rawl SM
J Palliat Med; 2018 Aug; 21(8):1107-1113. PubMed ID: 29905496
[TBL] [Abstract][Full Text] [Related]
28. Validation of a frailty index in older cancer patients with solid tumours.
McCarthy AL; Peel NM; Gillespie KM; Berry R; Walpole E; Yates P; Hubbard RE
BMC Cancer; 2018 Sep; 18(1):892. PubMed ID: 30217171
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits.
Fallowfield LJ; Catt SL; May SF; Matthews L; Shilling VM; Simcock R; Westwell S; Jenkins VA
Support Care Cancer; 2017 Jan; 25(1):237-244. PubMed ID: 27619389
[TBL] [Abstract][Full Text] [Related]
30. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
31. Role of Geriatric Oncologists in Optimizing Care of Urological Oncology Patients.
Droz JP; Boyle H; Albrand G; Mottet N; Puts M
Eur Urol Focus; 2017 Oct; 3(4-5):385-394. PubMed ID: 29128297
[TBL] [Abstract][Full Text] [Related]
32. Paradox of Prescribing Late Chemotherapy: Oncologists Explain.
Bluhm M; Connell CM; De Vries RG; Janz NK; Bickel KE; Silveira MJ
J Oncol Pract; 2016 Dec; 12(12):e1006-e1015. PubMed ID: 27650843
[TBL] [Abstract][Full Text] [Related]
33. Patient age and cancer treatment decisions. Patient and physician views.
Kutner JS; Vu KO; Prindiville SA; Byers TE
Cancer Pract; 2000; 8(3):114-9. PubMed ID: 11898135
[TBL] [Abstract][Full Text] [Related]
34. The use of palliative chemotherapy in pediatric oncology patients: a national survey of pediatric oncologists.
Kang TI; Hexem K; Localio R; Aplenc R; Feudtner C
Pediatr Blood Cancer; 2013 Jan; 60(1):88-94. PubMed ID: 23024072
[TBL] [Abstract][Full Text] [Related]
35. Geriatric oncology in Spain: survey results and analysis of the current situation.
Gironés R; Morilla I; Guillen-Ponce C; Torregrosa MD; Paredero I; Bustamante E; Del Barco S; Soler G; Losada B; Visa L; Llabrés E; Fox B; Firvida JL; Blanco R; Antonio M; Aparisi F; Pi-Figueras M; Gonzalez-Flores E; Molina-Garrido MJ; Saldaña J;
Clin Transl Oncol; 2018 Aug; 20(8):1087-1092. PubMed ID: 29327240
[TBL] [Abstract][Full Text] [Related]
36. [Geriatric assessment and prognostic scores in older cancer patient: Additional support to the therapeutic decision?].
Pamoukdjian F; Liuu E; Caillet P; Gisselbrecht M; Herbaud S; Boudou-Rouquette P; Zelek L; Paillaud E
Bull Cancer; 2017 Nov; 104(11):946-955. PubMed ID: 29150094
[TBL] [Abstract][Full Text] [Related]
37. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
[TBL] [Abstract][Full Text] [Related]
38. Age and clinical decision making in oncology patients.
Yellen SB; Cella DF; Leslie WT
J Natl Cancer Inst; 1994 Dec; 86(23):1766-70. PubMed ID: 7966414
[TBL] [Abstract][Full Text] [Related]
39. Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.
Agarwal A; Karikios DJ; Stockler MR; Morton RL
PLoS One; 2022; 17(10):e0273620. PubMed ID: 36269711
[TBL] [Abstract][Full Text] [Related]
40. Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists.
Day FL; Sherwood E; Chen TY; Barbouttis M; Varlow M; Martin J; Weber M; Sitas F; Paul C
Asia Pac J Clin Oncol; 2018 Dec; 14(6):431-438. PubMed ID: 29706029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
